Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 123,540,712
  • Shares Outstanding, K 1,478,821
  • Annual Sales, $ 32,753 M
  • Annual Income, $ 5,687 M
  • 60-Month Beta 0.97
  • Price/Sales 3.78
  • Price/Cash Flow 9.13
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 2.21
  • Number of Estimates 3
  • High Estimate 2.27
  • Low Estimate 2.17
  • Prior Year 1.90
  • Growth Rate Est. (year over year) +16.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.76 +0.94%
on 01/24/20
90.72 -7.91%
on 12/26/19
-6.31 (-7.02%)
since 12/24/19
3-Month
76.22 +9.60%
on 10/25/19
91.99 -9.19%
on 12/20/19
+6.74 (+8.78%)
since 10/24/19
52-Week
62.66 +33.32%
on 08/15/19
91.99 -9.19%
on 12/20/19
-2.34 (-2.72%)
since 01/24/19

Most Recent Stories

More News
What Lies Ahead for Healthcare ETFs in Q4 Earnings?

With earnings surprise in the cards, the healthcare sector is expected to witness substantial earnings growth of 4.4% in the fourth quarter, suggesting some room for potential upside for healthcare ETFs....

ABBV : 83.54 (-2.03%)
PFE : 39.82 (-2.19%)
MRK : 85.98 (-2.91%)
BMY : 64.16 (-4.05%)
FHLC : 49.93 (-1.67%)
XLV : 102.46 (-1.67%)
VHT : 192.63 (-1.77%)
IYH : 216.63 (-1.72%)
GILD : 63.15 (-1.24%)
AMGN : 225.59 (-4.02%)
Abbvie Inc Set to Possibly Rebound After Yesterday's Selloff of 1.88%

Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $86.39 to a high of $87.07. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $87.57 on...

ABBV : 83.54 (-2.03%)
How Trading Your Own Retirement Can Fleece Your Financial Future - January 23, 2020

From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.

ABBV : 83.54 (-2.03%)
SASR : 35.87 (-1.39%)
HTBK : 11.91 (-4.03%)
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, AbbVie (ABBV) closed at $87.20, marking a -0.9% move from the previous day.

ABBV : 83.54 (-2.03%)
J&J's (JNJ) Q4 Earnings Surpass Estimates, Sales Fall Short

J&J (JNJ) comes up with mixed fourth-quarter 2019 results.

JNJ : 148.32 (-0.14%)
ABBV : 83.54 (-2.03%)
MRK : 85.98 (-2.91%)
TEVA : 10.10 (-2.79%)
5 Big Drug/Biotech Stocks Set to Trump Q4 Earnings Estimates

Let us take a look at some drug/biotech stocks that are poised to beat on earnings in the fourth quarter.

MRK : 85.98 (-2.91%)
ABBV : 83.54 (-2.03%)
AZN : 49.28 (-1.83%)
AMGN : 225.59 (-4.02%)
ALXN : 105.27 (-3.02%)
Simple Secrets Anyone Can Use to Reach Early Retirement - January 22, 2020

Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments,...

ABBV : 83.54 (-2.03%)
HTBK : 11.91 (-4.03%)
ISBC : 11.81 (+0.17%)
AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue

In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of January 20, 2020 its issued share capital, excluding treasury shares, is comprised...

ABBV : 83.54 (-2.03%)
Roche's (RHHBY) Lymphoma Drug Polivy Gets Approval in Europe

Roche (RHHBY) obtains approval for Polivy in Europe for the treatment of adult patients with R/R DLBCL.

ABBV : 83.54 (-2.03%)
RHHBY : 41.2000 (-2.81%)
AMGN : 225.59 (-4.02%)
SGEN : 113.57 (-1.54%)
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks - January 20, 2020

The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate...

ABBV : 83.54 (-2.03%)
CMRE : 7.84 (-1.01%)
CCL : 47.52 (-3.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ABBV with:

Business Summary

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation...

See More

Key Turning Points

2nd Resistance Point 86.65
1st Resistance Point 85.09
Last Price 83.54
1st Support Level 82.37
2nd Support Level 81.21

See More

52-Week High 91.99
Last Price 83.54
Fibonacci 61.8% 80.79
Fibonacci 50% 77.32
Fibonacci 38.2% 73.86
52-Week Low 62.66

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar